Introduction
Fibrin is the main thrombus component. Its production being definitely lower in in-patients than in outpatients. is followed by activation of the fibrinolytic system, resulting in plasmin generation and subsequent fibrin lysis ( Figure 1 ). Dissolution of crosslinked fibrin leads to formation of specific degradation products, includ-
Methods for measuring DD in blood
ing D-dimer (DD),1 which can be easily detected and
The advantages and disadvantages of the various measured in both whole blood and plasma using methods that measure DD in blood are displayed in monoclonal antibodies directed against epitopes Table 1 . For clinical use in emergency situations, located in the DD fragment. In the past decade, DD rapid tests are mandatory. Among them, a whole testing has been established as a useful aid in the blood latex test (Simplired, Agen) that gives a diagnosis of venous thromboembolism (VTE).2 The present review updates experience on the use of DD testing for diagnosis of deep-vein thrombosis (DVT) of the lower limbs and pulmonary embolism (PE). Briefly, DD was found in the late 1980s and early 1990s to be highly sensitive (but non-specific) to the presence of VTE where clinically suspected in outpatients. In this population, the negative predictive value of a plasma DD concentration below a certain cutoff (usually about 500 mg/l) was more than 95%, thereby allowing one to rule out the disease in a substantial proportion (about one third) of patients. However, the diagnostic performances were strongly population to which it was applied, the specificity qualitative result in 2 min, and a rapid ELISA assay are increasingly referred to diagnostic centres, in spite of a low or very low clinical suspicion. This on plasma (Vidas DD, bioMerieux) that requires change in practice resulted in a decrease in the 35 min to produce a quantitative result, were submitprevalence of DVT among clinically-suspected ted to clinical testing over the past few years.
patients, which has dropped in our centre from 50% Unfortunately, latex tests, including the whole blood to 25% over the past 15 years. Even though nonSimplired test, have the disadvantages of the visual invasive diagnostic tests are less harmful and much reading (with potential interobserver disagreement) cheaper than venography, they are still relatively and a limited sensitivity to the presence of VTE expensive and require technical skills. Thus, a highly (Table 2) . On the other hand, the rapid ELISA test sensitive and simple test used as initial screening Vidas DD is highly sensitive to the presence of VTE, and ruling out DVT in a substantial proportion of but needs to be run on a commercial automated subjects, might save time and money, as demondevice. Other new quick tests, based on the ELISA or strated in the setting of PE diagnosis.5 The more latex agglutination principle, should undergo systemspecific ultrasonographic test would be applied only atic testing in clinical settings before recommending in patients presenting with a DD concentration above their use in suspected venous thromboembolism. the cutoff. Table 2 summarizes the diagnostic performances of the various methods to assay DD in suspected DD for ruling out deep-vein DVT. ELISA tests have a superior sensitivity to the presence of DVT compared with latex tests. At
thrombosis (DVT)
present time, the superiority of the Simplired test In patients with clinical signs and symptoms, B-mode over other latex tests is far from evident in patients venous compression ultrasonography or duplex scanwith suspected DVT. Published reports of sensitivity ning are presently used in clinical practice,4 contrast vary widely from paper to paper,8-11 ranging from venography still being the diagnostic gold standard.
an extremely poor 61%8 up to 100%.10 However, On the other hand, with increasing fear for DVT and data are still limited, and studies with larger numbers its immediate and late consequences (pulmonary of patients and adequate methodology are urgently needed. embolism and post-thrombotic syndrome), patients tic trials but still needs to be evaluated properly in DD for ruling out pulmonary specially designed, prospective studies.
embolism (PE) Diagnosis of recurrent venous
Clinical diagnosis of PE is unreliable, and the diagnostic gold standard, pulmonary angiography, is thromboembolism cumbersome, invasive and not without risk.
It may be very difficult to distinguish recurrent Perfusion/ventilation lung scintigraphy allows ruling venous thromboembolism from the sequelae of a out or ruling in PE in less than half of cases, and previous event. Sié et al. showed that DD levels patients with an abnormal, non-high-probability lung returned to normal values within 3 months after an scan pattern should theoretically undergo pulmonary acute DVT20 in most subjects, thereby implying that angiography. Recently, strategies were developed a low DD concentration measured in a patient that include lower-limbs venous compression ultrasuspected of a recurrent event could be used to rule sonography, which is highly specific for venous out recurrence. thromboembolism. Such policies reduce substantially the need for pulmonary angiography.15,16 On the Potential use of DD testing for confirming other hand, because sensitivity of DD to the presence PE of PE is extremely high (Table 2) , a concentration below the cutoff allows ruling out the disease with
The poor specificity of elevated DD plasma concena negative predictive value of more than 95% when tration is well known.2,21 Indeed, several conditions established methods are used.
are associated with fibrin formation and degradation, Table 2 summarizes the diagnostic performances such as infectious or inflammatory diseases, and of the various methods to assay DD in suspected PE.
cancer. Only 20% or even less of patients who are Sensitivity of all assays appears to be better for PE admitted with these conditions will present with a DD level below the critical cutoff of 500 mg/l, than for DVT, which may reflect a larger amount of which decreases the usefulness of testing in case of fibrin formed and degraded in the former. In addition, concomitant suspected venous thrombosis.21 ELISA assays and the whole-blood latex test seem to Nonetheless, in out-patients clinically suspected exhibit comparable performances (sensitivity to presof PE, the specificity of the classical ELISA was 41.4% ence of PE of >95%) but confidence intervals for (95% CI 37.0%-45.9%) in a large series of 671 sensitivity of the new tests are still wide, because of patients.12 This figure was greatly influenced by age, the relatively small patient populations studied so far.
ranging from 72% (30-39 year-old group) to 9% (>80 years of age). As a consequence, DD measurement would allow excluding PE in 2/3 out-patients without the disease under 60 years of age, but only
Other applications of DD in 1/5 patients older than 60.
measurement in suspected venous
The overall specificity of 41.4% of DD for the thromboembolism presence of PE was obtained for a cutoff of 500 mg/l (for the ELISA assay Asserachrom DD from Stago)
Screening of DVT in asymptomatic high-risk which was associated with a sensitivity of 99.5% patients (95% CI 97.2%-100%). Setting the cutoff at 4000 mg/l would result in a dramatic increase of specificity In a prospective trial of 185 consecutive patients (93.1%) while sensitivity would be lowered undergoing elective abdominal surgery who were to 49.5%.12 Detailed operating characteristics of DD submitted to bilateral ascending venography on the in suspected PE are displayed in Table 3 . These data 8th postoperative day, a plasma DD cutoff of imply that an out-patient clinically suspected of PE 3000 mg/l was able to discriminate between patients who presents with a DD level above 4000 mg/l has a with and without postoperative DVT with a sensitivity 551 likelihood of having PE, which may be sufficient and a specificity of 89% and 48%, respectively. 17 to initiate anticoagulant treatment, provided the prior We, therefore suggested that plasma measurement of clinical probability is sufficiently high. DD might be useful in thromboprophylactic studies for initial screening of patients, a level below 3000 mg/l excluding DVT (negative predictive value
Standardization of DD assays:
of 93%) whereas a concentration above the cutoff necessity or wishful thinking?
would require phlebographic confirmation. Similar results have been reported by others in general Different methods, different results surgery patients18 and by our group in patients undergoing total hip arthroplasty.19 Such an approach Several types of assays for DD are available (Table 1) and within each type, numerous commercial kits would be particularly valuable in thromboprophylac- testing, which is non-specific. Thus, test combinations will be used depending upon their performances but also upon their availability, and the costs. These exist which differ in many aspects, including the tests include, besides DD measurement, venous capture and the tagging antibody, the required compression ultrasonography,4 ventilation/perfusion sample dilution, the detection limit, and the incubalung scintigraphy,24 to some extent also echocardiotion time. In a systematic comparison of four ELISA graphy and spiral CT, and lastly, contrast venography assays in 151 plasma samples from patients clinically of lower limbs and pulmonary angiography. Test suspected of pulmonary embolism, van Beek et al.
combinations will also be based on the fact that DVT found intra-assay coefficients of variation in the and PE represent two clinical pictures of a common median values of 3.5% to 17%22 while the intercondition, venous thromboembolic disease, and that assay variation coefficients were very similar among diagnosing DVT in a patient clinically suspected the four assays (15-20%) . This rather poor reproduof PE allows to diagnose PE. In addition, the treatment cibility might account, at least in part, for the only of DVT and PE is basically the same. fair correlation (regression coefficients of about 0.60)
Finally, a diagnostic strategy should be viewed in among the various ELISA assays. Finally, the normal a Bayesian perspective, every test result being integvalues in a reference healthy population differed rated with the clinical probability of having the considerably between the tests. disease determined prior to any test.2,25,26 Figure 2 On the other hand, because the assays recognize displays two examples of simple, sequential diamore or less different components in plasma or in gnostic algorithms for suspected DVT or PE which blood and because various techniques are used, are presently being tested in a large-scale Swissheterogeneity of the results might have been anticipCanadian management trial. The sequences were ated. Thus, rather than calling for an unlikely standderived from a clinical decision-making model,25 ardization, efforts should focus on determining a a subsequent management trial16 and a costcritical cutoff for each individual assay, based on effectiveness analysis.5 In the strategy chosen for the test performances established in clinical studies suspected PE, DD testing as an initial screening, that were conducted according to the four steps followed by venous compression ultrasonography, described hereafter. yielded a 10% incremental cost reduction and a 40% reduction of necessary angiograms compared to the reference strategy. 
Conclusions and perspectives
(using Receiver Operating Characteristics curve analysis), and values of sensitivity and specificity of the The place of DD measurement in the diagnostic workup of suspected venous thromboembolism is test to the presence of venous thromboembolism, for the cutoff chosen; (iii) use of the test in so-called now well established. When using assays assessed in well-conducted clinical trials, the test can safely management trials, in which anticoagulation is withheld in patients with a DD concentration below the rule out DVT and PE if the concentration falls below a certain, assay-dependent cutoff. When used as the cutoff. A systematic three-month follow-up would allow detection of delayed events and establishment initial diagnostic step in an out-patient population with a prevalence of the disease of about 25%, this of the true diagnostic performance of the test; Figure 2 . D-Dimer (DD) testing in diagnostic algorithms of suspected DVT or PE. Due to its high sensitivity to venous thromboembolism, DD measurement can be used early in the diagnostic approach of deep-vein thrombosis (DVT) or pulmonary embolism (PE), a value below the critical cutoff allowing to rule out these diseases. If the DD concentration is above the cutoff, more specific tests are to be used along with prior clinical probability (PCP) assessment. The figures between brackets represent the numbers of patients with the corresponding outcome in a hypothetical cohort of 100 outpatients with clinically suspected DVT or PE, given a prevalence of the disease of about 25% in the population studied (estimations from data obtained in our institution, published in part11,15). simple test will exclude VTE in about 30% of patients the Ernst and Lucie Schmiedheiny Foundation, the Société Académique de Genève, and the Safra at a low cost. A widespread clinical application was made possible thanks the development of rapid, Foundation. single-test, and quantitative DD assays (and, possibly, more reliable latex tests) that can be used in the
